Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Intact Transition Epitope Mapping - Targeted High-Energy Rupture of Extracted Epitopes (ITEM-THREE).

Danquah BD, Röwer C, Opuni KFM, El-Kased R, Frommholz D, Illges H, Koy C, Glocker MO.

Mol Cell Proteomics. 2019 Aug;18(8):1543-1555. doi: 10.1074/mcp.RA119.001429. Epub 2019 May 30.

PMID:
31147491
2.

Apparent activation energies of protein-protein complex dissociation in the gas-phase determined by electrospray mass spectrometry.

Yefremova Y, Melder FTI, Danquah BD, Opuni KFM, Koy C, Ehrens A, Frommholz D, Illges H, Koelbel K, Sobott F, Glocker MO.

Anal Bioanal Chem. 2017 Nov;409(28):6549-6558. doi: 10.1007/s00216-017-0603-4. Epub 2017 Sep 12.

4.

Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis.

Singh A, Rajasekaran N, Hartenstein B, Szabowski S, Gajda M, Angel P, Bräuer R, Illges H.

Arthritis Res Ther. 2013;15(6):R222.

5.

Histamine 4 receptor plays an important role in auto-antibody-induced arthritis.

Nent E, Frommholz D, Gajda M, Bräuer R, Illges H.

Int Immunol. 2013 Jul;25(7):437-43. doi: 10.1093/intimm/dxt008. Epub 2013 Apr 1.

PMID:
23545338
6.

Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis.

Singh A, Leng L, Fan J, Gajda M, Bräuer R, Fingerle-Rowson G, Bucala R, Illges H.

Rheumatol Int. 2013 Sep;33(9):2301-8. doi: 10.1007/s00296-013-2713-4. Epub 2013 Mar 17.

7.

A monoclonal antibody against bovine adiponectin.

Raffelsieper M, Mielenz B, Häußler S, Sauerwein H, Mielenz M, Illges H.

Hybridoma (Larchmt). 2012 Dec;31(6):465-8. doi: 10.1089/hyb.2012.0054.

PMID:
23244328
8.

Enhanced CD21 expression and shedding in chronic lymphatic leukemia: a possible pathomechanism in disease progression.

Low HZ, Hilbrans D, Schmidt-Wolf IG, Illges H.

Int J Hematol. 2012 Sep;96(3):350-6. doi: 10.1007/s12185-012-1147-1. Epub 2012 Aug 17.

PMID:
22899340
9.

Maximal locomotor depression follows maximal ankle swelling during the progression of arthritis in K/BxN mice.

Frommholz D, Illges H.

Rheumatol Int. 2012 Dec;32(12):3999-4003. doi: 10.1007/s00296-011-2337-5. Epub 2012 Jan 1.

PMID:
22210276
10.

Genetic CD21 deficiency is associated with hypogammaglobulinemia.

Thiel J, Kimmig L, Salzer U, Grudzien M, Lebrecht D, Hagena T, Draeger R, Voelxen N, Bergbreiter A, Jennings S, Gutenberger S, Aichem A, Illges H, Hannan JP, Kienzler AK, Rizzi M, Eibel H, Peter HH, Warnatz K, Grimbacher B, Rump JA, Schlesier M.

J Allergy Clin Immunol. 2012 Mar;129(3):801-810.e6. doi: 10.1016/j.jaci.2011.09.027. Epub 2011 Oct 27. Erratum in: J Allergy Clin Immunol. 2014 Feb;133(2):604. Völxen, Nadine [corrected to Voelxen, Nadine].

PMID:
22035880
11.

JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis.

Denninger K, Rasmussen S, Larsen JM, Orskov C, Seier Poulsen S, Sørensen P, Christensen JP, Illges H, Odum N, Labuda T.

Am J Pathol. 2011 Oct;179(4):1884-93. doi: 10.1016/j.ajpath.2011.06.019. Epub 2011 Aug 11.

12.

Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.

Singh A, Vastert SJ, Prakken BJ, Illges H.

Rheumatol Int. 2012 Jun;32(6):1581-7. doi: 10.1007/s00296-011-1830-1. Epub 2011 Feb 17.

PMID:
21328056
13.

Flotillins are involved in the polarization of primitive and mature hematopoietic cells.

Rajendran L, Beckmann J, Magenau A, Boneberg EM, Gaus K, Viola A, Giebel B, Illges H.

PLoS One. 2009 Dec 22;4(12):e8290. doi: 10.1371/journal.pone.0008290.

14.

Histidine decarboxylase but not histamine receptor 1 or 2 deficiency protects from K/BxN serum-induced arthritis.

Rajasekaran N, Solomon S, Watanabe T, Ohtsu H, Gajda M, Bräuer R, Illges H.

Int Immunol. 2009 Nov;21(11):1263-8. doi: 10.1093/intimm/dxp092. Epub 2009 Sep 17.

PMID:
19762454
15.

Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process.

Boneberg EM, Illges H, Legler DF, Fürstenberger G.

Microvasc Res. 2009 Dec;78(3):325-31. doi: 10.1016/j.mvr.2009.06.012. Epub 2009 Jul 15.

PMID:
19615385
16.

MS characterization of apheresis samples from rheumatoid arthritis patients for the improvement of immunoadsorption therapy - a pilot study.

Kienbaum M, Koy C, Montgomery HV, Drynda S, Lorenz P, Illges H, Tanaka K, Kekow J, Guthke R, Thiesen HJ, Glocker MO.

Proteomics Clin Appl. 2009 Jul;3(7):797-809. doi: 10.1002/prca.200800232.

PMID:
21136988
17.

Ectodomain shedding and generation of two carboxy-terminal fragments of human complement receptor 2/CD21.

Hoefer MM, Illges H.

Mol Immunol. 2009 Aug;46(13):2630-9. doi: 10.1016/j.molimm.2009.04.036. Epub 2009 Jun 12.

PMID:
19524299
18.

Systemic reduction of soluble complement receptor II/CD21 during pregnancy to levels reminiscent of autoimmune disease.

Masilamani M, Rajasekaran N, Singh A, Low HZ, Albus K, Anders S, Behne F, Eiermann P, König K, Mindnich C, Ribarska T, Illges H.

Rheumatol Int. 2008 Sep;28(11):1137-41. doi: 10.1007/s00296-008-0604-x. Epub 2008 May 24.

PMID:
18500464
19.

Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain.

Hoefer MM, Aichem A, Knight AM, Illges H.

Mol Immunol. 2008 Apr;45(8):2127-37. doi: 10.1016/j.molimm.2007.12.015. Epub 2008 Mar 4.

PMID:
18295335
20.

Antiphospholipid syndrome patients display reduced titers of soluble CD21 in their sera irrespective of circulating anti-beta2-glycoprotein-I autoantibodies.

Singh A, Blank M, Shoenfeld Y, Illges H.

Rheumatol Int. 2008 May;28(7):661-5. doi: 10.1007/s00296-007-0503-6. Epub 2008 Jan 3.

PMID:
18172655
21.

Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice.

Kneilling M, Hültner L, Pichler BJ, Mailhammer R, Morawietz L, Solomon S, Eichner M, Sabatino J, Biedermann T, Krenn V, Weber WA, Illges H, Haubner R, Röcken M.

Arthritis Rheum. 2007 Jun;56(6):1806-16.

22.

Raft association and lipid droplet targeting of flotillins are independent of caveolin.

Rajendran L, Le Lay S, Illges H.

Biol Chem. 2007 Mar;388(3):307-14.

23.

Redox regulation of CD21 shedding involves signaling via PKC and indicates the formation of a juxtamembrane stalk.

Aichem A, Masilamani M, Illges H.

J Cell Sci. 2006 Jul 15;119(Pt 14):2892-902. Epub 2006 Jun 27.

24.

CD21 and CD62L shedding are both inducible via P2X7Rs.

Sengstake S, Boneberg EM, Illges H.

Int Immunol. 2006 Jul;18(7):1171-8. Epub 2006 Jun 1.

PMID:
16740600
25.

Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation.

Hoefer MM, Boneberg EM, Grotegut S, Kusch J, Illges H.

Int J Biol Macromol. 2006 May 30;38(3-5):259-67. Epub 2006 Mar 16.

PMID:
16624403
26.

D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells.

Boneberg EM, von Seydlitz E, Pröpster K, Watzl H, Rockstroh B, Illges H.

J Neuroimmunol. 2006 Apr;173(1-2):180-7. Epub 2005 Dec 27.

PMID:
16376996
27.

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles.

Spohn G, Schwarz K, Maurer P, Illges H, Rajasekaran N, Choi Y, Jennings GT, Bachmann MF.

J Immunol. 2005 Nov 1;175(9):6211-8.

28.

A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis.

Solomon S, Rajasekaran N, Jeisy-Walder E, Snapper SB, Illges H.

Eur J Immunol. 2005 Oct;35(10):3064-73.

29.

The role of the complement and the Fc gamma R system in the pathogenesis of arthritis.

Solomon S, Kassahn D, Illges H.

Arthritis Res Ther. 2005;7(4):129-35. Epub 2005 May 16. Review.

30.

Collection of soluble variants of membrane proteins for transcriptomics and proteomics.

Möller S, Mix E, Blüggel M, Serrano-Fernández P, Koczan D, Kotsikoris V, Kunz M, Watson M, Pahnke J, Illges H, Kreutzer M, Mikkat S, Thiesen HJ, Glocker MO, Zettl UK, Ibrahim SM.

In Silico Biol. 2005;5(3):295-311. Epub 2005 Apr 5.

PMID:
15984938
31.

Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes.

Hu HG, Illges H, Gruss C, Knippers R.

Int Immunol. 2005 Jun;17(6):789-96. Epub 2005 May 20.

PMID:
15908448
32.

Soluble CD21 in sera and synovial fluid of arthritic patients.

Grottenthaler T, von Kempis J, Goldacker S, Illges H.

Rheumatol Int. 2006 Jan;26(3):240-3. Epub 2005 Mar 16.

PMID:
15770483
33.

Reduction of soluble complement receptor 2/CD21 in systemic lupus erythomatosus and Sjogren's syndrome but not juvenile arthritis.

Masilamani M, Nowack R, Witte T, Schlesier M, Warnatz K, Glocker MO, Peter HH, Illges H.

Scand J Immunol. 2004 Dec;60(6):625-30.

34.

A new CD21low B cell population in the peripheral blood of patients with SLE.

Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, Warnatz K.

Clin Immunol. 2004 Nov;113(2):161-71.

PMID:
15451473
35.

Hydrostatic pressure induces apoptosis in the human leukaemic T-cell line Jurkat via the mitochondrial pathway.

Klett MV, Boneberg EM, Trenz K, Knippers R, Illges H.

Scand J Immunol. 2004 Oct;60(4):403-11.

36.

B cell activation leads to shedding of complement receptor type II (CR2/CD21).

Masilamani M, Kassahn D, Mikkat S, Glocker MO, Illges H.

Eur J Immunol. 2003 Sep;33(9):2391-7.

37.

Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.

Masilamani M, von Kempis J, Illges H.

Rheumatology (Oxford). 2004 Feb;43(2):186-90. Epub 2003 Jul 16.

PMID:
12867574
38.

Asymmetric localization of flotillins/reggies in preassembled platforms confers inherent polarity to hematopoietic cells.

Rajendran L, Masilamani M, Solomon S, Tikkanen R, Stuermer CA, Plattner H, Illges H.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8241-6. Epub 2003 Jun 25.

39.

Generation of three-dimensional pannus-like tissues in vitro from single cell suspensions of synovial fluid cells from arthritis patients.

Solomon S, Masilamani M, Mohanty S, Schwab JE, Boneberg EM, Illges H.

Rheumatol Int. 2004 Mar;24(2):71-6. Epub 2003 Jun 17.

PMID:
12811506
40.

Human IgG1/IgG3 cryoglobulin suggesting lack of allelic exclusion.

Mohanty S, Weiner SM, Mentele R, Vaith P, Lottspeich F, Illges H.

Mol Immunol. 2003 Jun;39(16):1003-11.

PMID:
12749907
41.

Identification of teleost Thy-1 and association with the microdomain/lipid raft reggie proteins in regenerating CNS axons.

Deininger SO, Rajendran L, Lottspeich F, Przybylski M, Illges H, Stuermer CA, Reuter A.

Mol Cell Neurosci. 2003 Apr;22(4):544-54.

PMID:
12727449
42.
43.

[Autoantibodies and the complement system--significance for pathogenesis of rheumatoid arthritis?].

Mierau R, Illges H.

Z Rheumatol. 2002 Aug;61(4):460-3. German. No abstract available.

PMID:
12426853
44.
45.

Cloning, expression, and alternative splicing of neogenin1 in zebrafish.

Shen H, Illges H, Reuter A, Stuermer CA.

Mech Dev. 2002 Oct;118(1-2):219-23.

46.

The lipid raft microdomain-associated protein reggie-1/flotillin-2 is expressed in human B cells and localized at the plasma membrane and centrosome in PBMCs.

Solomon S, Masilamani M, Rajendran L, Bastmeyer M, Stuermer CA, Illges H.

Immunobiology. 2002 Mar;205(1):108-19.

PMID:
11999340
47.

Few human autoimmune sera detect GPI.

Kassahn D, Kolb C, Solomon S, Bochtler P, Illges H.

Nat Immunol. 2002 May;3(5):411-2; author reply 412-3. No abstract available.

PMID:
11976712
48.

Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).

Solomon S, Kolb C, Mohanty S, Jeisy-Walder E, Preyer R, Schöllhorn V, Illges H.

Eur J Immunol. 2002 Mar;32(3):644-51.

49.
50.

Regulation of CD21 expression by DNA methylation and histone deacetylation.

Schwab J, Illges H.

Int Immunol. 2001 May;13(5):705-10.

PMID:
11312258

Supplemental Content

Loading ...
Support Center